Logo image of KS.CA

KLONDIKE SILVER CORP (KS.CA) Stock Fundamental Analysis

TSX-V:KS - TSX Venture Exchange - CA4987222060 - Common Stock - Currency: CAD

0.03  +0 (+20%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to KS. KS was compared to 822 industry peers in the Metals & Mining industry. Both the profitability and financial health of KS have multiple concerns. KS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

KS had negative earnings in the past year.
KS had a negative operating cash flow in the past year.
KS had negative earnings in each of the past 5 years.
KS had negative operating cash flow in 4 of the past 5 years.
KS.CA Yearly Net Income VS EBIT VS OCF VS FCFKS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -500K -1M -1.5M -2M -2.5M

1.2 Ratios

With a decent Return On Assets value of -3.86%, KS is doing good in the industry, outperforming 76.48% of the companies in the same industry.
KS's Return On Equity of -5.28% is fine compared to the rest of the industry. KS outperforms 74.79% of its industry peers.
Industry RankSector Rank
ROA -3.86%
ROE -5.28%
ROIC N/A
ROA(3y)-5.62%
ROA(5y)-7.75%
ROE(3y)-7.14%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
KS.CA Yearly ROA, ROE, ROICKS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -5 -10 -15

1.3 Margins

KS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KS.CA Yearly Profit, Operating, Gross MarginsKS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, KS has more shares outstanding
The debt/assets ratio for KS is higher compared to a year ago.
KS.CA Yearly Shares OutstandingKS.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
KS.CA Yearly Total Debt VS Total AssetsKS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -1.50, we must say that KS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.50, KS is in line with its industry, outperforming 42.18% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that KS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.04, KS is in line with its industry, outperforming 43.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z -1.5
ROIC/WACCN/A
WACCN/A
KS.CA Yearly LT Debt VS Equity VS FCFKS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

KS has a Current Ratio of 0.02. This is a bad value and indicates that KS is not financially healthy enough and could expect problems in meeting its short term obligations.
KS has a Current ratio of 0.02. This is amonst the worse of the industry: KS underperforms 87.27% of its industry peers.
A Quick Ratio of 0.02 indicates that KS may have some problems paying its short term obligations.
KS has a worse Quick ratio (0.02) than 87.15% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
KS.CA Yearly Current Assets VS Current LiabilitesKS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M 4M

0

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.76% over the past year.
EPS 1Y (TTM)4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KS.CA Yearly Revenue VS EstimatesKS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024
KS.CA Yearly EPS VS EstimatesKS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
KS.CA Price Earnings VS Forward Price EarningsKS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KS.CA Per share dataKS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02 0.03 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for KS!.
Industry RankSector Rank
Dividend Yield N/A

KLONDIKE SILVER CORP

TSX-V:KS (3/7/2025, 7:00:00 PM)

0.03

+0 (+20%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner ChangeN/A
Market Cap8.07M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.6
P/tB 0.6
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.86%
ROE -5.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.62%
ROA(5y)-7.75%
ROE(3y)-7.14%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3631.82%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -1.5
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)36752.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y81.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y100.99%
OCF growth 3YN/A
OCF growth 5YN/A